R71C (p.Arg71Cys) variant of PAH (Phenylalanine-4-hydroxylase)

R71C (p.Arg71Cys) in PAH (Phenylalanine-4-hydroxylase) is a missense change. Clinical records from EBI and UniProt describe it as likely pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.71 / 1. The record also includes population frequency data, published literature, and structural context.

R71C (p.Arg71Cys) variant details